ChinYang Chemical Corporation (KRX:051630)
South Korea · Delayed Price · Currency is KRW 1,574.00
+34.00 (2.21%)
Last updated: Jun 2, 2026, 3:00 PM KST
ChinYang Chemical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 19,097 | 18,564 | 24,527 | 28,281 | 29,090 | 34,785 |
Other Revenue | -0 | -0 | -0 | - | - | -0 |
| 19,097 | 18,564 | 24,527 | 28,281 | 29,090 | 34,785 | |
Revenue Growth (YoY) | -16.32% | -24.31% | -13.27% | -2.78% | -16.37% | -19.64% |
Cost of Revenue | 17,265 | 16,963 | 24,314 | 25,731 | 26,482 | 34,110 |
Gross Profit | 1,832 | 1,601 | 213.18 | 2,551 | 2,608 | 675.42 |
Selling, General & Admin | 1,779 | 1,834 | 3,857 | 4,224 | 3,260 | 4,028 |
Research & Development | 176.39 | 173.33 | 183.84 | 170.89 | 120.82 | 170.06 |
Amortization of Goodwill & Intangibles | 59.3 | 59.12 | 39.62 | 1.02 | 1.53 | 2.08 |
Other Operating Expenses | 117.67 | 114.44 | 167.47 | 195.09 | 198.33 | 214.04 |
Operating Expenses | 2,283 | 2,344 | 4,353 | 4,698 | 3,664 | 4,532 |
Operating Income | -451.06 | -743.28 | -4,140 | -2,147 | -1,056 | -3,856 |
Interest Expense | -1,428 | -1,638 | -385.27 | -150.22 | -10 | -1.68 |
Interest & Investment Income | 988.18 | 919.38 | 15.06 | 59.64 | 98.01 | 121.49 |
Currency Exchange Gain (Loss) | -353.8 | -351.61 | -8.49 | -2.31 | -39.35 | -19.35 |
Other Non Operating Income (Expenses) | -32.79 | 104.67 | 103.23 | 119.25 | 99.31 | 77.66 |
EBT Excluding Unusual Items | -1,278 | -1,709 | -4,415 | -2,121 | -907.66 | -3,678 |
Gain (Loss) on Sale of Investments | 3,468 | 2,509 | - | - | - | - |
Gain (Loss) on Sale of Assets | -19.76 | -11.26 | -7.25 | -5.8 | -331.37 | 2,248 |
Asset Writedown | - | - | -65.92 | -65.12 | - | -133.92 |
Pretax Income | 2,171 | 788.88 | -4,488 | -2,192 | -1,239 | -1,564 |
Income Tax Expense | -23.94 | -107.61 | -0.09 | -21.08 | -126.23 | 648.22 |
Net Income | 2,195 | 896.49 | -4,488 | -2,171 | -1,113 | -2,213 |
Net Income to Common | 2,195 | 896.49 | -4,488 | -2,171 | -1,113 | -2,213 |
Shares Outstanding (Basic) | - | 21 | 17 | 16 | 13 | 12 |
Shares Outstanding (Diluted) | - | 21 | 17 | 16 | 13 | 12 |
Shares Change (YoY) | - | 27.51% | 5.23% | 17.77% | 11.80% | - |
EPS (Basic) | - | 42.29 | -269.94 | -137.39 | -82.95 | -184.39 |
EPS (Diluted) | - | 42.29 | -269.94 | -137.39 | -82.95 | -184.39 |
Free Cash Flow | -359.9 | -1,074 | -1,453 | -12,438 | -9,188 | -5,152 |
Free Cash Flow Per Share | - | -50.66 | -87.39 | -787.20 | -684.86 | -429.31 |
Gross Margin | 9.59% | 8.62% | 0.87% | 9.02% | 8.96% | 1.94% |
Operating Margin | -2.36% | -4.00% | -16.88% | -7.59% | -3.63% | -11.09% |
Profit Margin | 11.49% | 4.83% | -18.30% | -7.67% | -3.82% | -6.36% |
Free Cash Flow Margin | -1.88% | -5.79% | -5.92% | -43.98% | -31.59% | -14.81% |
EBITDA | 1,446 | 1,154 | -2,205 | -1,202 | -532.98 | -3,233 |
EBITDA Margin | 7.57% | 6.21% | -8.99% | -4.25% | -1.83% | -9.29% |
D&A For EBITDA | 1,897 | 1,897 | 1,934 | 945.24 | 522.65 | 623.61 |
EBIT | -451.06 | -743.28 | -4,140 | -2,147 | -1,056 | -3,856 |
EBIT Margin | -2.36% | -4.00% | -16.88% | -7.59% | -3.63% | -11.09% |
Advertising Expenses | - | 22 | 72.2 | 153.35 | 87.82 | 138.34 |